Diaz Roberto J, Zobel Carsten, Cho Hee Cheol, Batthish Michelle, Hinek Alina, Backx Peter H, Wilson Gregory J
Division of Cardiovascular Research, The Hospital for Sick Children, Toronto, Ontario, Canada.
Circ Res. 2004 Aug 6;95(3):325-32. doi: 10.1161/01.RES.0000137727.34938.35. Epub 2004 Jul 1.
Volume regulatory Cl- channels are key regulators of ischemic preconditioning (IPC). Because Cl- efflux must be balanced by an efflux of cations to maintain cell membrane electroneutrality during volume regulation, we hypothesize that I(K1) channels may play a role in IPC. We subjected cultured cardiomyocytes to 60-minute simulated ischemia (SI) followed by 60-minute of simulated reperfusion (SR) and assessed percent cell death using trypan blue staining. Ischemic preconditioning (10-minute SI/10-minute SR) significantly (P<0.0001) reduced the percent cell death in nontransfected cardiomyocytes [IPC(CM) 18.0+/-2.1% versus control (C(CM)) 48.3+/-1.0%]. IPC protection was not altered by overexpression of the reporter gene (enhanced green fluorescent protein, EGFP). However, overexpression of dominant-negative Kir2.1 or Kir2.2 genes using adenoviruses (AdEGFPKir2.1DN or AdEGFPKir2.2DN) encoding the reporter gene EGFP prevented IPC protection [both IPC(CM)+AdEGFPKir2.1DN 45.8+/-2.3% (mean+/-SEM) and IPC(CM)+AdEGFPKir2.2DN 47.9+/-1.4% versus IPC(CM); P<0.0001] in cultured cardiomyocytes (n=8 hearts). Transfection of cardiomyocytes with AdEGFPKir2.1DN or AdEGFPKir2.2DN did not affect cell death in control (nonpreconditioned) cardiomyocytes (both C(CM)+ AdEGFPKir2.1DN 45.8+/-0.7% and C(CM)+AdEGFPKir2.2DN 46.2+/-1.3% versus C(CM); not statistically significant). Similar effects were observed in both cultured (n=5 hearts) and freshly isolated (n=4 hearts) ventricular cardiomyocytes after I(K1) blockade with 20 micromol/L BaCl2 plus 1 micromol/L nifedipine (to prevent Ba2+ uptake). Nifedipine alone neither protected against ischemic injury nor blocked IPC protection. Our findings establish that I(K1) channels play an important role in IPC protection.
容积调节性氯离子通道是缺血预处理(IPC)的关键调节因子。由于在容积调节过程中,氯离子外流必须由阳离子外流来平衡以维持细胞膜电中性,我们推测内向整流钾通道(I(K1))可能在IPC中发挥作用。我们对培养的心肌细胞进行60分钟的模拟缺血(SI),随后进行60分钟的模拟再灌注(SR),并使用台盼蓝染色评估细胞死亡百分比。缺血预处理(10分钟SI/10分钟SR)显著(P<0.0001)降低了未转染心肌细胞的细胞死亡百分比[IPC(CM)为18.0±2.1%,而对照组(C(CM))为48.3±1.0%]。报告基因(增强型绿色荧光蛋白,EGFP)的过表达并未改变IPC的保护作用。然而,使用编码报告基因EGFP的腺病毒(AdEGFPKir2.1DN或AdEGFPKir2.2DN)过表达显性负性Kir2.1或Kir2.2基因可阻止IPC的保护作用[IPC(CM)+AdEGFPKir2.1DN为45.8±2.3%(平均值±标准误)以及IPC(CM)+AdEGFPKir2.2DN为47.9±1.4%,与IPC(CM)相比;P<0.0001],在培养的心肌细胞中(n = 8个心脏)。用AdEGFPKir2.1DN或AdEGFPKir2.2DN转染心肌细胞对对照组(未预处理)心肌细胞的细胞死亡没有影响(C(CM)+ AdEGFPKir2.1DN为45.8±0.7%以及C(CM)+AdEGFPKir2.2DN为46.2±1.3%,与C(CM)相比;无统计学意义)。在用20 μmol/L BaCl2加1 μmol/L硝苯地平(以防止Ba2+摄取)阻断I(K1)后,在培养的(n = 5个心脏)和新鲜分离的(n = 4个心脏)心室心肌细胞中均观察到类似的效果。单独使用硝苯地平既不能预防缺血损伤,也不能阻断IPC的保护作用。我们的研究结果表明,I(K1)通道在IPC保护中起重要作用。